Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Forecast to Publish a Funding Opportunity Announcement for Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

    The National Cancer Institute will fund hypothesis-driven research in cancer epidemiology cohort studies to address gaps in cancer causes and survivorship, supporting cohort maintenance and data sharing.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

    Explore existing data to uncover cancer risk insights, seeking to understand outcomes like survival and treatment response.

    HHS-NIH11Due Nov 5, 2026· 9d$1,750,000

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

    This grant supports researchers in analyzing existing data to understand cancer risk and related outcomes, aiming to address key scientific questions in cancer research.

    HHS-NIH11Due Nov 16, 2026· 20d$275,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    HHS-NIH11Forecasted Jun 4, 2027$150,000Forecasted

    Forecast to Publish a Funding Opportunity Announcement for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

    The National Cancer Institute will soon invite applications to develop innovative, user-friendly informatics technologies that advance cancer research, spanning early tool development to initial dissemination.

    HHS-NIH11Due Oct 19, 2027$300,000

    Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

    Support for innovative research to improve cancer control through behavior modification, screening, and understanding etiologic factors, with the aim of advancing population-based cancer studies.

    HHS-NIH11Due Nov 16, 2026· 20d